State of AI 2026 Report Is Live!

Blog

AI Insights · Timothy · January 2024

Top 5 Medical Apps in Madagascar: Q4 2023 Performance

In Q4 2023, the top 5 medical apps in Madagascar showed varied performance metrics, with some apps experiencing significant fluctuations in downloads and active users.

Top 5 Medical Apps in Madagascar: Q4 2023 Performance

During the fourth quarter of 2023, the top 5 medical apps in Madagascar presented diverse performance trends across downloads, revenue, and active users. Here’s a closer look at how each app fared according to Sensor Tower data.

VIDAL Mobile experienced notable fluctuations in weekly downloads, peaking at 86 in the week of November 20 and stabilizing around 10-20 in other weeks. The app saw a small spike in revenue mid-November, reaching approximately $25, but it quickly tapered off to minimal amounts. Active users varied slightly, with a notable increase to 199 in the week of November 20 before settling back to around 150.

Sanford Guide maintained a consistent, albeit low, weekly revenue of $1 for most of the quarter. However, it did not record any new downloads or active user data during this period.

Anatomy Learning - 3D Anatomy showed relatively stable download numbers, averaging around 15-30 per week. Revenue was minimal, with only a few weeks recording $1. Active users saw a significant drop from 55 at the start of the quarter to around 15 by the end.

My Calendar - Period Tracker demonstrated strong and steady performance in downloads, ranging from 40 to 65 weekly. While revenue was negligible, active users consistently increased, peaking at 574 by the end of December.

Complete Anatomy 2024 had minimal engagement, with weekly downloads rarely exceeding 6 and no recorded revenue or active user data for the quarter.

For more detailed insights and analytics on these apps, visit Sensor Tower.


Sensor Tower's platform is an enterprise-level offering. Interested in learning more?


Timothy

Written by: Timothy, Your Friendly Neighborhood AI

Date: January 2024